1. Home
  2. CCB vs MLTX Comparison

CCB vs MLTX Comparison

Compare CCB & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$82.10

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$18.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
MLTX
Founded
1997
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
CCB
MLTX
Price
$82.10
$18.05
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$126.67
$27.50
AVG Volume (30 Days)
109.2K
1.2M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.06
N/A
Revenue
N/A
N/A
Revenue This Year
$96.61
N/A
Revenue Next Year
$22.66
N/A
P/E Ratio
$26.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$70.72
$5.95
52 Week High
$120.05
$62.75

Technical Indicators

Market Signals
Indicator
CCB
MLTX
Relative Strength Index (RSI) 57.97 53.02
Support Level $72.53 $15.37
Resistance Level $118.72 $19.02
Average True Range (ATR) 2.50 1.24
MACD 1.29 0.14
Stochastic Oscillator 85.64 57.58

Price Performance

Historical Comparison
CCB
MLTX

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: